Anupam Kotwal is an Endocrinology/Metabolic physician affiliated with Nebraska Medical Center. OpenAlex indexes 118 publications with 1,817 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Emile @ 42nd St
Omaha, NE 681980001
Telephone
402-559-8700Registry record last updated 10 Jul 2019.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ascendis Pharma Endocrinology IncProgram year20257 payments$11,306openpaymentsdata.cms.gov ↗
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- Amgen Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
71.1%l-Thyroxine66.3%Levothyroxine Sodium100%Part D≥74 patientsThyroid Hormone Synthesis Inhibitor4.8%Methimazole100%Part D<11 patientsMetabolism & gastrointestinal
13.6%Vitamin D3 Analog8.8%Calcitriol100%Part D<11 patientsInsulin Analog4.8%Lantus Solostar100%Part D<11 patientsSensory organs
8.2%Corticosteroid8.2%Hydrocortisone100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025
Journal of the National Comprehensive Cancer Network
2025 - Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier
The Journal of Clinical Endocrinology & Metabolism
2024 - Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer
Frontiers in Immunology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Stephen Rennard, MD
Nebraska Medical Center
Matthew Lunning, DO
Nebraska Medical Center
Kevin Garvin, MD
Nebraska Medical Center
Timothy McCashland, MD
Nebraska Medical Center
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”